These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20127861)

  • 21. Anti-CCL25 antibody prolongs skin allograft survival by blocking CCR9 expression and impairing splenic T-cell function.
    Li J; Xiong T; Xiao R; Xiong A; Chen J; Altaf E; Zheng Y; Zhu G; He Y; Tan J
    Arch Immunol Ther Exp (Warsz); 2013 Jun; 61(3):237-44. PubMed ID: 23456208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CC chemokine ligand 25 enhances resistance to apoptosis in CD4+ T cells from patients with T-cell lineage acute and chronic lymphocytic leukemia by means of livin activation.
    Qiuping Z; Jei X; Youxin J; Wei J; Chun L; Jin W; Qun W; Yan L; Chunsong H; Mingzhen Y; Qingping G; Kejian Z; Zhimin S; Qun L; Junyan L; Jinquan T
    Cancer Res; 2004 Oct; 64(20):7579-87. PubMed ID: 15492285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody blockade of CCL25/CCR9 ameliorates early but not late chronic murine ileitis.
    Rivera-Nieves J; Ho J; Bamias G; Ivashkina N; Ley K; Oppermann M; Cominelli F
    Gastroenterology; 2006 Nov; 131(5):1518-29. PubMed ID: 17101325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCR9-mediated signaling through β-catenin and identification of a novel CCR9 antagonist.
    Lee S; Heinrich EL; Li L; Lu J; Choi AH; Levy RA; Wagner JE; Yip ML; Vaidehi N; Kim J
    Mol Oncol; 2015 Oct; 9(8):1599-611. PubMed ID: 26003048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion.
    Johnson-Holiday C; Singh R; Johnson E; Singh S; Stockard CR; Grizzle WE; Lillard JW
    Int J Oncol; 2011 May; 38(5):1279-85. PubMed ID: 21344163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the CC chemokine receptor 9/TECK interaction in apoptosis.
    Youn BS; Yu KY; Oh J; Lee J; Lee TH; Broxmeyer HE
    Apoptosis; 2002 Jun; 7(3):271-6. PubMed ID: 11997671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wnt5a and CCL25 promote adult T-cell acute lymphoblastic leukemia cell migration, invasion and metastasis.
    Deng X; Tu Z; Xiong M; Tembo K; Zhou L; Liu P; Pan S; Xiong J; Yang X; Leng J; Zhang Q; Xiao R; Zhang Q
    Oncotarget; 2017 Jun; 8(24):39033-39047. PubMed ID: 28380463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CCL25/CCR9 interactions are not essential for colitis development but are required for innate immune cell protection from chronic experimental murine colitis.
    Wurbel MA; Le Bras S; Ibourk M; Pardo M; McIntire MG; Coco D; Geha RS; Fiebiger E; Snapper SB
    Inflamm Bowel Dis; 2014 Jul; 20(7):1165-76. PubMed ID: 24874458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abrogation of CC chemokine receptor 9 ameliorates collagen-induced arthritis of mice.
    Yokoyama W; Kohsaka H; Kaneko K; Walters M; Takayasu A; Fukuda S; Miyabe C; Miyabe Y; Love PE; Nakamoto N; Kanai T; Watanabe-Imai K; Charvat TT; Penfold ME; Jaen J; Schall TJ; Harigai M; Miyasaka N; Nanki T
    Arthritis Res Ther; 2014 Sep; 16(5):445. PubMed ID: 25248373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CCR9 Antagonists in the Treatment of Ulcerative Colitis.
    Bekker P; Ebsworth K; Walters MJ; Berahovich RD; Ertl LS; Charvat TT; Punna S; Powers JP; Campbell JJ; Sullivan TJ; Jaen JC; Schall TJ
    Mediators Inflamm; 2015; 2015():628340. PubMed ID: 26457007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 17-Allylamino-17-Demethoxygeldanamycin and the Enhancement of PS-341-Induced Lung Cancer Cell Death by Blocking the NF-κB and PI3K/Akt Pathways.
    Lee KH; Jang AH; Yoo CG
    Am J Respir Cell Mol Biol; 2015 Sep; 53(3):412-21. PubMed ID: 25633180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin-converting enzyme inhibition down-regulates the pro-atherogenic chemokine receptor 9 (CCR9)-chemokine ligand 25 (CCL25) axis.
    Abd Alla J; Langer A; Elzahwy SS; Arman-Kalcek G; Streichert T; Quitterer U
    J Biol Chem; 2010 Jul; 285(30):23496-505. PubMed ID: 20504763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasis.
    Gupta P; Sharma PK; Mir H; Singh R; Singh N; Kloecker GH; Lillard JW; Singh S
    Oncotarget; 2014 Oct; 5(20):10170-9. PubMed ID: 25296976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CCL25 and CCR9 is a unique pathway that potentiates pannus formation by remodeling RA macrophages into mature osteoclasts.
    Umar S; Palasiewicz K; Van Raemdonck K; Volin MV; Romay B; Ahmad I; Tetali C; Sweiss N; Amin MA; Zomorrodi RK; Shahrara S
    Eur J Immunol; 2021 Apr; 51(4):903-914. PubMed ID: 33347617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemokine 25-induced signaling suppresses colon cancer invasion and metastasis.
    Chen HJ; Edwards R; Tucci S; Bu P; Milsom J; Lee S; Edelmann W; Gümüs ZH; Shen X; Lipkin S
    J Clin Invest; 2012 Sep; 122(9):3184-96. PubMed ID: 22863617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer.
    Caromile LA; Dortche K; Rahman MM; Grant CL; Stoddard C; Ferrer FA; Shapiro LH
    Sci Signal; 2017 Mar; 10(470):. PubMed ID: 28292957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MLN3126, an antagonist of the chemokine receptor CCR9, ameliorates inflammation in a T cell mediated mouse colitis model.
    Igaki K; Komoike Y; Nakamura Y; Watanabe T; Yamasaki M; Fleming P; Yang L; Soler D; Fedyk E; Tsuchimori N
    Int Immunopharmacol; 2018 Jul; 60():160-169. PubMed ID: 29730559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
    Li CM; Narayanan R; Lu Y; Hurh E; Coss CC; Barrett CM; Miller DD; Dalton JT
    Int J Oncol; 2010 Oct; 37(4):1023-30. PubMed ID: 20811725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine.
    Amersi FF; Terando AM; Goto Y; Scolyer RA; Thompson JF; Tran AN; Faries MB; Morton DL; Hoon DS
    Clin Cancer Res; 2008 Feb; 14(3):638-45. PubMed ID: 18245522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diallyl trisulfide-induced apoptosis of bladder cancer cells is caspase-dependent and regulated by PI3K/Akt and JNK pathways.
    Shin DY; Kim GY; Hwang HJ; Kim WJ; Choi YH
    Environ Toxicol Pharmacol; 2014 Jan; 37(1):74-83. PubMed ID: 24309133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.